Home › Compare › KBPH vs EPRT

KBPH vs EPRT: Dividend Comparison 2026

KBPH yields 200.00% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KBPH wins by $119.30M in total portfolio value
10 years
KBPH
KBPH
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full KBPH calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — KBPH vs EPRT

📍 KBPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKBPHEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KBPH + EPRT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
KBPH pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KBPH
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, KBPH beats the other by $51,138,767.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KBPH + EPRT for your $10,000?

KBPH: 50%EPRT: 50%
100% EPRT50/50100% KBPH
Portfolio after 10yr
$59.71M
Annual income
$30,094,468.50/yr
Blended yield
50.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

KBPH
No analyst data
Altman Z
51.0
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KBPH buys
0
EPRT buys
0
No recent congressional trades found for KBPH or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKBPHEPRT
Forward yield200.00% ✓3.92%
Annual dividend / share$2.00 ✓$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29% ✓
Portfolio after 10y$119.36M ✓$63.4K
Annual income after 10y$60,176,096.29 ✓$12,840.73
Total dividends collected$112.49M ✓$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: KBPH vs EPRT ($10,000, DRIP)

YearKBPH PortfolioKBPH Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$30,700$20,000.00$11,205$505.18+$19.5K → KBPH
2$90,232$57,383.18$12,672$682.46+$77.6K → KBPH
3$254,173$157,624.56$14,490$930.48+$239.7K → KBPH
4$686,927$414,961.74$16,786$1,282.69+$670.1K → KBPH
5$1,783,118$1,048,106.39$19,753$1,791.56+$1.76M → KBPH
6$4,450,613$2,542,677.12$23,677$2,541.64+$4.43M → KBPH
7$10,693,420$5,931,263.38$29,008$3,672.99+$10.66M → KBPH
8$24,760,608$13,318,648.86$36,463$5,425.08+$24.72M → KBPH
9$55,315,649$28,821,798.66$47,238$8,221.57+$55.27M → KBPH
10$119,363,841$60,176,096.29$63,385$12,840.73+$119.30M → KBPH

KBPH vs EPRT: Complete Analysis 2026

KBPH — Stock

Kyto Technology and Life Science, Inc. is a venture capital firm specializing in startups and early stage companies. Its investments are either in the form of secured convertible debt paying interest and offering a discount upon conversion to preferred shares, or directly into preferred shares. The firm seeks to invest in technology and life science companies. It does not lead financing transactions. The firm makes 50% investments in the United States and the remaining in Canada and Israel. KYTO Technology and Life Science, Inc. was formerly known as Kyto BioPharma, Inc. and changed its name in April 2018. Kyto Technology and Life Science, Inc. was founded in 1999 and is based in Los Altos Hills, California with an additional office in Scotts Valley, California.

Full KBPH Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this KBPH vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KBPH vs SCHDKBPH vs JEPIKBPH vs OKBPH vs KOKBPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.